Peroxisome proliferator-activated receptors (PPARs) are key regulators of metabolism. Inhibitors of PPARs are studied for their potential in managing metabolic disorders like diabetes and obesity. They function by interfering with the activation of PPARs, affecting fat storage, glucose metabolism, and inflammation. These inhibitors show promise in developing treatments for conditions related to metabolic dysfunction.
